Clinical Trial Update: Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating atovaquone in combination with radical chemoradiotherapy for locally advanced non-small cell lung cancer has completed enrollment and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atovaquone (Atovaquone)

Snippet

Sponsor: University of Oxford | Conditions: Locally Advanced Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-11-25